Results 21 to 30 of about 75,972 (251)

Synthesis of Hybrid Fluoroquinolone-Boron Complexes and Their Evaluation in Cervical Cancer Cell Lines

open access: yesJournal of Chemistry, 2019
Quinolones are a family of antimicrobial agents that have been used in antibacterial and anticancer chemotherapy. Fluoroquinolone targets DNA gyrase and topoisomerase IV enzymes affecting several cellular processes, like cell death and proliferation; the
Hiram Hernández-López   +6 more
doaj   +1 more source

Ofloxacin-induced Fixed Drug Eruptions

open access: yesJournal of Integrated Health Sciences, 2020
Fixed drug eruption (FDE) is a form of drug induced dermatosis condition. Drugs which most commonly induce FDE are antibiotics, anticonvulsants, antiviral agents and even nonsteroidal anti-inflammatory drugs.
Kushalkumar H. Gohel   +4 more
doaj   +1 more source

Fluoroquinolone-related adverse events resulting in health service use and costs: A systematic review [PDF]

open access: yes, 2019
Background and objectivesAdverse events (AEs) associated with the use of fluoroquinolone antimicrobials include Clostridium difficile associated diarrhea (CDAD), liver injury and seizures. Yet, the economic impact of these AEs is seldom acknowledged. The
Kati M. Viljemaa (6640568)   +11 more
core   +1 more source

Fluoroquinolone-Resistant Escherichia coli Infections after Transrectal Biopsy of the Prostate in the Veterans Affairs Healthcare System

open access: yesPathogens and Immunity, 2016
Background: Recent reports suggest that infections due to fluoroquinolone-resistant Escherichia coli (E. coli) are an increasingly common complication of transrectal biopsy of the prostate (TBP) in the United States.
Elie Antoun Saade   +4 more
doaj   +1 more source

Fluoroquinolones and Anaerobes [PDF]

open access: yesClinical Infectious Diseases, 2006
The usefulness of fluoroquinolones for the treatment of mixed aerobic and anaerobic infections has been investigated since these agents started being used in clinical practice. Newer compounds have increased in vitro activity against anaerobes, but clinically relevant susceptibility breakpoints for these bacteria have not been established ...
Gary E, Stein, Ellie J C, Goldstein
openaire   +2 more sources

Fluoroquinolone heteroresistance, antimicrobial tolerance, and lethality enhancement

open access: yesFrontiers in Cellular and Infection Microbiology, 2022
With tuberculosis, the emergence of fluoroquinolone resistance erodes the ability of treatment to interrupt the progression of MDR-TB to XDR-TB.
Amit Singh   +4 more
doaj   +1 more source

Emergence and global spread of epidemic healthcare-associated clostridium difficile [PDF]

open access: yes, 2012
Epidemic C. difficile (027/BI/NAP1) has rapidly emerged in the past decade as the leading cause of antibiotic-associated diarrhea worldwide. However, the key events in evolutionary history leading to its emergence and the subsequent patterns of global ...
Hawkey, P.r   +154 more
core   +1 more source

Impact of Reduced Fluoroquinolone Use on Clostridioides difficile Infections Resulting From the Fluoroquinolone-Resistant Ribotype 027 Strain in a Veterans Affairs Medical Center

open access: yesPathogens and Immunity, 2019
Background: Fluoroquinolone restriction has been proposed as a control measure for Clostridioides difficile infection (CDI) outbreaks associated with fluoroquinolone-resistant ribotype 027 strains.
Sarah N. Redmond   +4 more
doaj   +1 more source

Efficacy of Triple Antibiotic Paste, Moxifloxacin, Calcium Hydroxide And 2% Chlorhexidine Gel In Elimination of E. Faecalis: An In vitro Study [PDF]

open access: yesJournal of Clinical and Diagnostic Research, 2017
Introduction: Root canal treatment is incomplete without usage of intra canal medicaments. They help in the reduction of bacterial count and its by-products, making canals clean and decreasing postoperative pains.
Ashik Ali Lakhani   +7 more
doaj   +1 more source

The insulinotropic effect of fluoroquinolones [PDF]

open access: yesBiochemical Pharmacology, 2009
Antimicrobial fluoroquinolones induce, with strongly varying frequency, life-threatening hypoglycemias, which is explained by their ability to block K(ATP) channels in pancreatic B-cells and thus to initiate insulin secretion. In apparent contradiction to this, we observed that none of the fluoroquinolones in this study (gatifloxacin, moxifloxacin ...
Ghaly, Hani   +6 more
openaire   +2 more sources

Home - About - Disclaimer - Privacy